• Skip to primary navigation
  • Skip to content
  • Skip to footer
Gynesonics

Gynesonics

Advancing technology. Improving women's lives.

  • Sonata Fibroid Treatment
    • About Uterine Fibroids
    • The Sonata® System
    • Peer-Reviewed Publications
    • Visit SonataTreatment.com
  • In the News
    • Sonata In the News
    • Press Releases
  • Company
    • About Us
    • Management
    • Investors
    • Board of Directors
    • Awards
    • Compliance
    • Careers
  • Resources
    • Safety Information
    • Education Resource Center
    • Request for Medical or Scientific Information
  • Manuals
  • Contact Us

Compliance

State of California Compliance Program Declaration

As part of our continued commitment to compliance, Gynesonics, Inc. (“Gynesonics”) has developed and implemented a Comprehensive Compliance Program consistent with the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) Compliance Program Guidance for Pharmaceutical Manufacturers, and with applicable state and federal laws relating to the marketing and promotion of the company’s products. The compliance program is designed in accordance with the AdvaMed Code on Interactions with Health Care Professionals, which is substantially equivalent to the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals (PhRMA Code) but reflects the unique interactions between medical technology companies and health care professionals. To the best of our knowledge and based on our good faith understanding of all applicable statutory and regulatory requirements, Gynesonics is in compliance with our Comprehensive Compliance Program and with the requirements of the California Health and Safety Code § 119400-119402. Gynesonics will evaluate and update its Compliance Program, as necessary and appropriate. Gynesonics will make conforming changes to our Comprehensive Compliance Program within six months of any update or revision of the Compliance Program Guidance or AdvaMed Code.

Copies of this Declaration and a description of our Comprehensive Compliance Program may be obtained by contacting our Corporate Compliance Department at compliance@gynesonics.com or the Gynesonics corporate headquarters at 844-343-6859.

Dated: February 9, 2021

Footer

  • Privacy Policy
  • Terms of Use
  • Patents
  • Safety Information

© Copyright 2021 Gynesonics · All Rights Reserved · WS 05198 Rev. H

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Gynesonics
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Privacy Policy

More information about our Privacy Policy